Dr. Harald F. Stock, CEO Grünenthal
“Millions of people in Europe suffer from chronic pain. However, patients , their relatives and care givers struggle with a disrespect of their suffering by society and health care systems. Often they are faced with limited access to appropriate pain treatment. A strong pain patient representation in Europe is urgently needed. That is why Grünenthal is enthusiastic to hear about the newly formed Pain Alliance Europe (PAE). We wish PAE to become a strong European voice to improve patients’ quality of life and future access to innovative pain care for patients in all of Europe.”
John Young, Regional President, EuCan – Primary Care, Pfizer, Europe, Canada
“As many as 100 million Europeans with chronic pain want to be active members of society, but many feel their condition stands in their way. Progress is only possible through partnership between stakeholders committed to solve this problem together to improve the lives of patients suffering from chronic pain.
As a company long committed to being an active partner in this dialogue, Pfizer welcomes Pain Alliance Europe and looks forward to the strength this collaboration will bring to the voice of chronic pain patients.”
